Alpine Immune Sciences, Inc.

Ownership Transactions Reported by 21 Insiders

Industry
Pharmaceutical Preparations
Location
188 East Blaine St., Suite 200, Seattle, WA

There are no Buy or Sell transactions made by insiders since 10/13/2024

Alpine Immune Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Decheng Capital China Life Sciences USD Fund III, L.P. 10%+ Owner $83.9M Jan 18, 2024
Jay Venkatesan Director, 10%+ Owner $36.6M Jul 15, 2022
Alpine ImmunoSciences, L.P. 10%+ Owner $33.1M Sep 17, 2021
Decheng Capital Global Healthcare Fund (Master), LP 10%+ Owner $22.1M Nov 9, 2023
Frazier Life Sciences VIII, L.P. 10%+ Owner $18.9M Feb 11, 2022
Mitchell Gold Executive Chairman and CEO, Director $0 May 18, 2024
Peter A. Thompson Director $0 May 18, 2024
Christopher Peetz Director $0 May 20, 2024
Xiangmin Cui Director, 10%+ Owner $0 May 18, 2024
Ulrich Martin Fuhs Chief Accounting Officer $0 May 20, 2024
Orbimed Advisors Llc Director $0 May 18, 2024
Robert E. Conway Director $0 May 20, 2024
Stanford L. Peng President & Head of Research and Development $0 May 20, 2024
Remy Durand Chief Business Officer $0 May 20, 2024
James N. Topper Director $0 May 18, 2024
James Paul Rickey Senior Vice President, Chief Financial Officer and Corporate Secretary $0 May 20, 2024
Zelanna Goldberg Chief Medical Officer Jun 1, 2021
Jorn Drappa Director May 20, 2024
Natasha Hernday Director May 20, 2024
Andrew Seth Sandler Chief Medical Officer Jan 5, 2023
Wolfgang Dummer Chief Medical Officer Oct 2, 2023

Recent Insider Transactions by Companies or Individuals for Alpine Immune Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.